Multiple unit pharmaceutical preparation
US5753265A · kind A · utility
68Cited by
2References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 1995 |
| Grant date | May 19, 1998 |
| Priority date | — |
| Expiry date | Jun 22, 2015 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P1/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A new pharmaceutical multiple unit tableted dosage form containing as active ingredient an acid labile H.sup.+ K.sup.+ -ATPase inhibitor or an alkaline salt thereof or one of its single enantiomers or an alkaline salt thereof, a method for the manufacture of such a formulation, and the method of treatment with such a formulation in medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.